These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 35373500)

  • 1. Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.
    Yang M; Wei L
    Liver Int; 2022 Aug; 42(9):1981-1990. PubMed ID: 35373500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B.
    Cho H; Chang Y; Lee JH; Cho YY; Nam JY; Lee YB; Lee DH; Cho EJ; Yu SJ; Kim YJ; Lee JM; Yoon JH
    J Clin Gastroenterol; 2020 Aug; 54(7):633-641. PubMed ID: 31033805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.
    Yu MW; Lin CL; Liu CJ; Huang YW; Hu JT; Wu WJ; Wu CF
    J Formos Med Assoc; 2022 Aug; 121(8):1478-1487. PubMed ID: 34764005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.
    Li J; Yang HI; Yeh ML; Le MH; Le AK; Yeo YH; Dai CY; Barnett S; Zhang JQ; Huang JF; Trinh HN; Wong C; Wong C; Hoang JK; Cheung R; Yu ML; Nguyen MH
    J Infect Dis; 2021 Jul; 224(2):294-302. PubMed ID: 33249474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis.
    Wong YJ; Nguyen VH; Yang HI; Li J; Le MH; Wu WJ; Han NX; Fong KY; Chen E; Wong C; Rui F; Xu X; Xue Q; Hu XY; Leow WQ; Goh GB; Cheung R; Wong G; Wong VW; Yu MW; Nguyen MH
    Clin Mol Hepatol; 2023 Jul; 29(3):705-720. PubMed ID: 37157776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B.
    Huang SC; Su TH; Tseng TC; Chen CL; Hsu SJ; Liao SH; Hong CM; Liu CH; Lan TY; Yang HC; Liu CJ; Chen PJ; Kao JH
    Hepatol Int; 2023 Oct; 17(5):1139-1149. PubMed ID: 37247045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study.
    Yao R; Lu S; Xue R; Wang J; Qiu Y; Chen Y; Liu J; Zhu L; Zhan J; Jiang S; Yin S; Tong X; Ding W; Li J; Zhu C; Huang R; Wu C
    Ann Hepatol; 2024; 29(1):101155. PubMed ID: 37742745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
    Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of non-alcoholic fatty liver disease in Asia.
    Wong SW; Chan WK
    Indian J Gastroenterol; 2020 Feb; 39(1):1-8. PubMed ID: 32152903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B.
    Mak LY; Hui RW; Fung J; Liu F; Wong DK; Cheung KS; Yuen MF; Seto WK
    J Hepatol; 2020 Oct; 73(4):800-806. PubMed ID: 32504663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALT Levels in Treatment-Naive, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A US Nationwide Study.
    Chang CY; Kam L; Dang N; Cheung R; Nguyen MH
    Dig Dis; 2022; 40(4):497-505. PubMed ID: 34348281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the relationship between nonalcoholic fatty liver disease and hepatocellular carcinoma in patients with prior hepatitis B virus infection].
    Chen L; Wang KF; Zhao Z; You QH; Wu YY; Sun J
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):52-56. PubMed ID: 35152669
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma.
    Yoon JS; Lee HY; Chung SW; Kim SW; Chang Y; Lee YB; Cho EJ; Lee JH; Yu SJ; Kim H; Yoon JH; Kim YJ
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1960-1968. PubMed ID: 32128882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis B virus infection in Asian countries.
    Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Hepatic Steatosis on the Natural History of HBV Infection.
    Suliman I; Abdelgelil N; Kassamali F; Hassanein TI
    Clin Liver Dis; 2019 Aug; 23(3):433-450. PubMed ID: 31266618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan.
    Su HJ; Kao JH; Tseng TC; Yang HC; Su TH; Chen PJ; Liu CJ
    J Formos Med Assoc; 2020 Oct; 119(10):1476-1482. PubMed ID: 32499209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion.
    Shi YW; Yang RX; Fan JG
    World J Gastroenterol; 2021 Jul; 27(26):3971-3983. PubMed ID: 34326608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.
    Yip TC; Wong GL; Chan HL; Tse YK; Lam KL; Lui GC; Wong VW
    J Hepatol; 2019 Mar; 70(3):361-370. PubMed ID: 30367899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta-analysis.
    Zhou R; Yang L; Zhang B; Gu Y; Kong T; Zhang W; Sun L; Liu C; Kong N; Li J; Shi J
    J Viral Hepat; 2023 Oct; 30(10):793-802. PubMed ID: 37533208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.